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Background: There is growing evidence that home telemonitoring can be advantageous in societies with
increasing prevalence of chronic diseases.
The main objective of this study is to evaluate the effect of a primary care-based telemonitoring intervention on
the number and length of hospital admissions.
Methods: A randomised controlled trial was carried out across 20 health centres in Bilbao (Basque Country, Spain)
to assess the impact of home telemonitoring on in-home chronic patients compared with standard care. The study
lasted for one year. Fifty-eight in-home patients, diagnosed with heart failure (HF) and/or chronic lung disease
(CLD), aged 14 or above and with two or more hospital admissions in the previous year were recruited. The
intervention consisted of daily patient self-measurements of respiratory-rate, heart-rate, blood pressure, oxygen
saturation, weight, body temperature and the completion of a health status questionnaire using PDAs. Alerts were
generated when pre-established thresholds were crossed. The control group (CG) received usual care. The primary
outcome measure was the number of hospital admissions that occurred at 12 months post-randomisation. The
impact of telemonitoring on the length of hospital stay, use of other healthcare resources and mortality was also
explored.
Results: The intervention group (IG) included 28 patients and the CG 30. Patient baseline characteristics were
similar in both groups. Of the 21 intervention patients followed-up for a year, 12 had some admissions (57.1%),
compared to 19 of 22 controls (86.4%), being the difference statistically significant (p = 0.033, RR 0.66; 95%CI 0.44 to
0.99). The mean hospital stay was overall 9 days (SD 4.3) in the IG versus 10.7 (SD 11.2) among controls, and for
cause-specific admissions 9 (SD 4.5) vs. 11.2 (SD 11.8) days, both without statistical significance (p = 0.891 and 0.927,
respectively). Four patients need to be telemonitored for a year to prevent one admission (NNT). There were more
telephone contacts in the IG than in the CG (22.6 -SD 16.1- vs. 8.6 -SD 7.2-, p = 0.001), but fewer home nursing visits
(15.3 -SD 11.6- vs. 25.4 -SD 26.3-, respectively), though the difference was not statistically significant (p = 0.3603).
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Conclusions: This study shows that telemonitoring of in-home patients with HF and/or CLD notably increases the
percentage of patients with no hospital admissions and indicates a trend to reduce total and cause-specific
hospitalisations and hospital stay. Home telemonitoring can constitute a beneficial alternative mode of healthcare
provision for medically unstable elderly patients.
Trial registration: Current Controlled Trials ISRCTN89041993
Keywords: Telemonitoring, Primary care, Effectiveness, Hospital admissions, In-home patients, Chronic diseases,
Heart failure, Chronic lung disease, ElderlyBackground
Home telemonitoring comprises the use of information
and communication technology from the patient home
so that clinical parameters and other clinical data can be
sent, both digitally or over the telephone, to the health
professionals managing the patient care [1]. The regular
collection of such medical information allows profes-
sionals or clinical support teams conducting comprehen-
sive monitoring of patients with chronic and complex
conditions and adjusting treatments, as well as facilitat-
ing the early identification of worsening episodes, which
if not detected quickly often lead to emergency depart-
ment attendances and/or hospital admissions [1,2]. As
demonstrated by various studies, such as the Strategic
Intelligence Monitor on Personal Health Systems phase
2 (SIMPHS 2) in Europe, this is an area that is undergo-
ing exponential growth with the technology being ever
more widely deployed [1,2]. This tendency can be attri-
buted to health systems seeking new approaches and
strategies to respond to a growing demand for health
and social resources due to population ageing and the
associated growth in the prevalence of chronic disease
and comorbidity [1].
Recently, a number of literature reviews have been
published providing new evidence on the usefulness of
home telemonitoring in the management of patients
with chronic diseases [3-6]. Our team commissioned a
systematic literature review to assess the effectiveness of
home telemonitoring in heart failure (HF) and chronic
obstructive pulmonary disease (COPD) [3]; 12 reviews
and 24 randomised controlled trials (RCTs) on HF and 3
reviews and 7 RCTs on COPD were analysed. In patients
with HF, telemonitoring showed a reduction in mortality
and in the number of all-cause hospitalisations, as well
as a positive effect on quality of life and on adherence
to treatment; while there was not a clear trend in the
length of hospital stay, compared to usual care. In pa-
tients with COPD, both telemonitoring and structured
telephone support reduced the number of all-cause hos-
pital admissions; but there were no conclusive data on
mortality or use of other healthcare resources [3].
Further, two systematic literature reviews on home
telemonitoring have so far been published by the CochraneCollaboration. Initially, in 2000, the effects of telemedicine
were assessed compared to face-to-face care, showing that
there was little evidence on the clinical benefits of tele-
medicine and that new research was needed to explore
the potential benefits of the new technology [7]. More
recently, another Cochrane review assessed the effect of
structured telephone support and telemonitoring pro-
grammes compared to standard care in patients with HF,
concluding that both approaches had the effect of redu-
cing the risk of all-cause mortality and hospital admissions
in these patients, as well as improving quality of life (QoL)
and decreasing healthcare costs [4].
Additionally, two other recent systematic reviews and
meta-analyses have been undertaken in order to assess
the effect of telemonitoring in patients with HF [5] and
COPD [6]. In HF patients, telemonitoring was shown to
reduce mortality, and several studies suggested that hos-
pitalisations and healthcare resources use were also de-
creased. In COPD patients, the authors found that both
telephone contact and device-based telemonitoring re-
duced hospital admissions and emergency department
attendances [5,6].
In the United Kingdom, the Whole System Demonstra-
tor (WSD) [8,9], the largest RCT to date in this field,
including 3,230 patients and 179 general practices was
launched in 2008. The study assesses the impact on the
use of healthcare services and quality of life of a two-
component intervention: telecare (remote monitoring of
individuals’ lifestyle and safety confirmation) and telehealth
(which involves the telemonitoring of 3,230 patients with
diabetes, HF or COPD). The results of this study will pro-
vide a solid evidence base. Some preliminary findings have
already emerged and suggest reductions in hospital admis-
sions and length of stay, emergency department visits,
mortality and costs [9].
HF and chronic lung disease (CLD) (witch mostly
comprises COPD and asthma) are both characterised by
the functional limitation and clinical progression. In fact,
the prospect of new readmissions and patient survival
are generally worsened by the hospital admissions de-
rived from these conditions. Yet, the quality of the care
for patients affected by these diseases can be improved
by changing from a model based on the management of
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the maintenance of the basal status (through structured
telephone support or telemonitoring in the home) [3].
Nevertheless, to date, there is a paucity of research with
the focus on interventions in which the management of
the telemonitoring systems lays directly into the hands
of primary care professionals (at local health centres).
Moreover, few studies have considered the monitoring
of more than one disease through the same telemo-
nitoring system and, as a result, there are more data
available for some diseases than others, the most con-
sistent findings having been obtained for HF [10]. The
present study addresses the gaps in the existing litera-
ture and highlights the importance of primary care in
the management of chronic patients and the recognition
of comorbidity as one of the main characteristics of such
patients [11].
This paper reports the results of a randomised controlled
trial, the TELBIL study. The trial protocol has been pub-
lished elsewhere [12]. The main objective of the study was
to assess the effect of a primary care-based telemonitoring
system on the number and length of hospital admissions
in patients with HF and/or CLD at 12 months post-
randomisation compared with the standard health care
practice. In addition to the effect on hospitalisations, we
also report the impact of the telemonitoring intervention
on the use of other healthcare resources (emergency de-
partment attendances, home visits by primary care pro-
fessionals, appointments at the health centre or with
specialists, and telephone calls), and on mortality, as well
as the association between hospitalisations and alerts gen-
erated by the telemonitoring system in the five days prior
to the hospital admissions.Methods
Study design and setting
This is a randomised controlled trial with a one-year
follow-up and analysis at 3, 6 and 12 months post-
randomisation. In the intervention group (IG), in addition
to the standard practice, patients were monitored using a
telemonitoring procedure, while the control group (CG)
received usual care. The intervention ran from February
2010 to August 2011, including the period of patient re-
cruitment over the first 6 months, with the participation
of 20 of the 24 health centres in the Bilbao Primary Care
Health District. This urban health region serves a catch-
ment population of 390.000 people, of whom around 27%
are over 60 years old. The team of professionals in charge
of the first level of healthcare is made up of 239 general
practitioners (GPs), 326 nurses and 40 pediatricians. Ac-
ceptance to participate was an inclusion criterion for both
health professionals and patients. Figure 1 outlines the
general study design, showing the flow of patients throughthe trial. Further details concerning the methodology of
the trial can be found in the published study protocol [12].
Eligible patients
Home care adult patients (individuals who receive rou-
tine healthcare at home due to lack of or severe difficul-
ties with mobility), diagnosed with HF and/or CLD, aged
14 or above, with a history of at least two hospital ad-
missions in the previous year, at least one of these ad-
missions having been associated with one of the two
conditions under study were included in the trial. The
patients excluded from the study were the following:
those in residential care, patients receiving regular moni-
toring or treatment by specialists or hospital services
(such as, patients on hemodialysis or rehabilitation prog-
rammes), those in the terminal phases (with a life expec-
tancy under 6 months) of other illnesses (not HF or
CLD) patients with established cognitive impairment
and those not willing to participate were excluded from
the study. Patient randomisation and recruitment pro-
cesses are described in detail in the study protocol [12].
Ethics approval
The study was approved by the Ethics Committee for
Scientific Research (CEIC, Basurto University Hospital,
Bizkaia). Patients or relatives gave written informed con-
sent prior to participating in the study. Patients’ identity
was preserved at all times during the course of the trial.
Description of the intervention
In addition to the usual care, the IG was followed-up
through by telemonitoring, which consisted of daily
transmissions from the patients’ homes of the following
self-measured clinical parameters using a smart phone-
personal digital assistant (PDA) with the help of the
caregivers: blood oxygen saturation, blood pressure,
heart and respiratory rates, body weight and tempera-
ture; the first three parameters being transferred to the
PDA by Bluetooth wireless technology. Additionally,
patients completed a brief health status questionnaire
aimed at assessing the patient’s perception of his/her
medical and functional condition. The questionnaire also
contained items concerning compliance with medication
and diet. All data were stored on a Web-based platform
and were accessible by health professionals (i.e.: the pa-
tient’s assigned general practitioner (GP) and nurse at
the health centre) during business hours from Monday
to Friday. The telemonitoring system comprised per-
sonalised alerts set for each patient, with messages being
sent to the Web platform when the recorded parameters
fell outside the pre-established limits (which could be
adjusted over time). The established threshold values
were essential for the monitoring of the patient’s condi-
tion and for the detection of unusual changes. When the
Figure 1 Flow of participants through the TELBIL trial.
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were triggered via the PDA terminal and the clinical staff
acted according to the medical condition of the patient.
Real alerts were differentiated from false alarms through
the assessment of all the clinical information and the
health status questionnaire received through the telemoni-
toring system. Therefore, even if an alarm was triggered
for a specific clinical parameter, it was the patient’s overall
health status that was taken into consideration by health-
care professionals, before taking any further action. Pa-
tients were advised to call the emergency services through
the telemonitoring system at weekends and at times when
the health centres were closed.
In the CG, patients received only usual care, consisting
of regular medical examinations in line with the
established programmes for monitoring home-based pa-
tients. The frequency of the medical examinations varieddepending on the clinical, social and family situation of
each patient. Additionally, the GP and/or nurse visited
or called the patient on demand in the event of a deteri-
oration in the medical condition.
All health professionals participating in the study (for
both, IG and CG) received specific training aimed at
strengthening and standardising the management of the
clinical conditions under study.Study variables
Initial assessment and baseline data
The variables described below were analysed. At baseline,
(i.e., at the moment when patients were included in the
study), sociodemographic and clinical data were collected
together with the use of healthcare resources over the pre-
vious year:
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date of birth and age, gender, health centre, assigned GP
and nurse, level of education, social and family charac-
teristics (aiming at identifying a lack of support on the
basis of assessing factors including poverty, loneliness,
isolation, social exclusion and recent widowhood).
The following clinical data were also recorded: diagnosis
of HF or CLD, based on the computerised primary care
registry and hospital medical records, specifying the ae-
tiology, degree of severity of the disease (based on the
FEV1 – forced expiratory volume in one second – for
COPD and on the NYHA – New York Heart Associa-
tion – classification and the ejection fraction for HF),
requirements of home oxygen therapy; the Charlson co-
morbidity index score [13]; regular medication (taken from
medical records and confirmed by health professionals
and/or patients themselves or their relatives); treatment
adherence measured using the Morisky Adherence Scale
(the original 4-item version) [14]; the number of hospital
admissions (noting whether they were cause-specific, that
is, related to the conditions under study) and the mean
duration of the hospital stay; and the use of other
healthcare resources during the year prior to the inclusion
in the study (emergency department attendances; appoint-
ments with specialists; home visits, including both sche-
duled visits and those prompted by the telemonitoring of
the patient; and other contacts with health centre profes-
sionals by telephone or face-to-face, even if patients them-
selves did not attend, for administrative tasks, follow-up,
prescriptions, etc.).
Outcome measures
The primary outcome measure was the number of hos-
pital admissions that occurred in a period of 12 months
post-randomisation. The hospitalisations were classified
as due to HF, due to CLD (i.e., COPD, asthma and other
respiratory conditions) and non-cardiorespiratory causes.
Secondary outcome measures included the length of
hospital stay (number of bed-days for emergency admis-
sions with a primary diagnosis of HF, CLD and other
causes during 12 months after randomisation), mortality
rates and use of other healthcare resources (emergency
department attendances, home visits, appointments at
the health centres and with the specialists and telephone
calls). We also assessed the relationship between the
hospitalisations and the number of alerts generated by
the telemonitoring system in the five days leading up to
the corresponding admissions.
Sample size
Prior to the start of the trial, we had estimated that thirty
patients would be recruited in each of the study groups,
the main constraints being the number of available devices
and the number of potential patients fulfilling the inclu-sion criteria in the Bilbao Primary Care Health Region.
Thus, if 30 patients had been included in each group, and
assuming a 10% loss to follow-up at 12 months, we es-
timated a statistical power of 72% to detect significant
differences between the CG and the IG in the mean num-
ber of total admissions with a level of significance of 5%
(assuming that the mean number of admissions in the CG
had been 3.5, the standard deviation 1.7, and there had
been a 35% decrease of hospitalisations in the IG with
respect to the CG). However, there have been some varia-
tions with respect to the statistical power on completion
of the trial due to recruitment limitations and follow-up
losses, which will be explained in detail in the discussion
section.
Statistical analysis
For the descriptive analysis, frequencies and percentages
were calculated for categorical variables, and mean and
standard deviation (SD) or median and interquartile
range (IQR) for continuous variables. Baseline sociode-
mographic and clinical data of the two groups (IG and
CG) were compared to assess the homogeneity. Both the
primary and secondary outcome measures (number of
hospital admissions and length of hospital stay, mortality
rates, and use of healthcare resources) were also com-
pared between the two groups of patients at 3, 6 and
12 months. For the comparison of qualitative variables
Chi-square or Fisher’s exact tests were used, while for
quantitative variables Student’s t-tests or non-parametric
Wilcoxon tests were employed, respectively, depending
on whether or not the data were normally distributed.
For the number of hospital admissions at 12 months
post-randomisation, the primary outcome measure, we es-
timated the relative risk (RR) of the occurrence of at least
one admission (for any cause) in intervention patients
compared to control patients. Additionally, the incidence
rate ratios for total and cause-specific admissions in inter-
vention patients compared to controls was also estimated.
Finally, we compared the risk of admissions for all causes
and for causes related to the conditions under study at
12 months of follow-up, in the two groups of patients after
adjusting for the baseline variables found to be statistically
significant in the assessment of group homogeneity. For
this purpose, logistic regression analysis was applied, con-
sidering the occurrence of at least one admission as the
dependent variable, the assigned group (CG vs. IG, the
main independent variable) and other adjustment vari-
ables (i.e., lack of social support) as independent variables.
The data are presented as odd ratios (OR) with 95% confi-
dence intervals (95% CI). In addition, we estimated the
number needed to treat (NNT), in terms of provision of
telemonitoring support to prevent one hospital admission
in a year. For the calculation of the NNT the relative risk
of having no hospital admission in the IG and in the CG
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tients with no admissions in the IG – proportion of pa-
tients with no admissions in the CG), and its 95% CI [15].
On the other hand, we compared the variables descri-
bing attendances and use of other healthcare resources in
the year prior to the inclusion in the study and after
12 months of follow-up in each group of patients, using
the paired t-test or the non-parametric Wilcoxon signed-
rank test when the normality assumption was not met.
Furthermore, differences in the changes in these variables
between the two groups of patients (IG and CG) were
assessed, using the Student’s t-tests or non-parametric
Wilcoxon tests.
The level of statistical significance was set at p < 0.05.
The analyses were performed using SAS for Windows,
version 9.2 (SAS Institute, Cary, NC, USA) and the IBM
SPSS Statistics, version 19 (IBM, Somers, NY, USA).
Results
We recruited and randomly allocated 28 patients (from
14 different health centres) to the intervention group
and 30 patients (from 6 different health centres) to the
control group. Twenty-two candidate patients were ex-
cluded before randomisation: 11 did not meet the inclu-
sion criteria (4 were institutionalised, 4 were not home
care patients and 3 were difficult to follow-up), 5 de-
clined to participate and 2 whose corresponding health
professionals did not wish to take part in the study,
while the other 4 died. The 12-month follow-up was
completed by 21 patients in the IG (of the initial 28 pa-
tients, 3 died, 3 withdrew from the study and 1 was
institutionalised), and by 22 patients in the CG (of the
initial 30 patients, 8 died during the study period).
Baseline characteristics of the participating patients
The mean age of the 58 patients included in the study
was 81 (SD 7.5) years, and 58.6% of them were men.
Overall, 46.5% of patients had the two medical condi-
tions targeted in the trial (HF and CLD) simultaneously,
while 27.6% had only HF and 25.9% had only CPD. More
than half (57.1%) needed permanent oxygen therapy in
the home, 86.2% had a Charlson index score above 2
(high comorbidity), and only 12% obtained a Barthel
Index score above 90 (which indicated little dependence)
as opposed to 34.5% of patients scoring below 60 (show-
ing severe or total dependence). The patients included
in the study took an average of 10.6 (SD 3.2) medica-
tions every day and during the previous year to the start
of the study were visited at home a median of 22.5 times
(range 3 to 139) and had a median of 3 hospitalisations
(range 2 to 9). At baseline, the above mentioned charac-
teristics were similar for the patients in the two groupsacross all the variables except that those in the IG had a
significantly lower level of social support (p = 0.038), as
shown in Table 1. With regard to the specific diagnoses
within the medical conditions under study, the most
common cause of HF was ischaemic heart disease
(34.9%), and 78.6% of patients with CLD had COPD with
different levels of severity: moderate (17.4%), severe
(21.7%) and very severe (60.9%). No statistically signifi-
cant differences were observed in the diagnoses between
the study groups (p = 0.723). In the period prior to the
study, home visits by the health professionals were car-
ried out by nurses in 77.3% of cases, and there were no
statistically significant differences in the number of
nurse home visits between the two groups, with a me-
dian of 11.5 (IQR 7.5 to 23.5) visits for the patients in
the IG and a median of 21 (IQR 9 to 28) for the patients
in the CG (p = 0.169); similarly the number of home
visits conducted by the GPs were comparable, with
a median of 6 (IQR 3 to 7) and 4.5 (IQR 2 to 8) visits
in the intervention and control groups, respectively
(p = 0.303).
Effect of home telemonitoring on hospital admissions
At 12 months of follow-up, the RR of hospitalisation for
the patients in the IG compared to those in the CG was
0.66 for all-cause hospital admissions (95% CI 0.44 to 0.99,
p = 0.033) and 0.74 (95% CI 0.48 to 1.14, p = 0.159) when
only the cause-specific admissions (for respiratory or
heart-related problems) were considered (see Table 2). Of
the 21 patients in the IG who completed the 12-month
follow-up, 9 had no hospital admissions at all, compared to
3 among the patients in the CG (p = 0.033) (with 9 and 5
patients with no admissions in the IG and CG respectively
if cause-specific hospitalisations were considered). In pa-
tients who completed the 12-month follow-up, the NNT
with telemonitoring to prevent one hospitalisation over a
year was 4 for all-cause admissions (95% CI 2 to 28) and 5
for cause-specific admissions, the latter not being statisti-
cally significant. Considering the total number of days of
follow-up of all the patients who initiated the study (8,828
and 9,970 in the IG and the CG, respectively), all-cause ad-
missions (53 and 68 in the IG and CG, respectively) and
cause-specific admissions (44 and 60 in the IG and the
CG, respectively), the incidence rate ratios between the pa-
tients in the IG and CG were 0.88 (95% CI 0.61 to 1.26) for
all-cause admissions and 0.83 (95% CI 0.56 to 1.22) for
cause-specific admissions. These correspond to 12% and
17% lower rates of hospitalisations among patients in the
IG as compared to patients in the CG. Further, the OR of
all-cause admission at 12 months post-randomisation for
patients in the IG compared to those in the CG was 0.21
(95% CI 0.05 to 0.94, p = 0.04). Logistic multivariate regres-
sion analysis was conducted, showing that the independent
variable (i.e., lack of social support) was non-significant.
Table 1 Comparison of the baseline sociodemographic characteristics, clinical characteristics and use of healthcare
resources in the intervention and control groups
IG CG p-value I
(n = 28) (n = 30)
Sociodemographic variables
Sex, n (%) 0.198
Men 14 (50%) 20 (66.7%)
Women 14 (50%) 10 (33.3%)
Age (years), mean (SD) 80.7 (9) 81.3 (6) 0.653
Living with:, n (%) 0.553
alone 4 (14.3%) 2 (6.7%)
spouse/partner 11 (39.3%) 15 (50%)
Others (other relatives, formal career, etc.) 13 (46.4%) 13 (43.3%)
Caregiver, n (%) 0.149
Spouse/partner 10 (35.7%) 16 (53.3%)
Daughter 9 (32.1%) 8 (26.7%)
Other relative 4 (14.3%) 0 (0%)
Other 5 (17.9%) 6 (20%)
Lack of social support II, n (%) 8 (28.6%) 2 (6.7%) 0.038
Clinical and functional variables
Disease-related reason for inclusion, n (%) 0.596
Heart failure 6 (21.2%) 10 (33.3%)
Lung disease 8 (28.6%) 7 (23.3%)
Both 14 (50%) 13 (43.4%)
Home oxygen therapy, n (%) 16 (57.1%) 14 (46.7%) 0.425
Comorbidity Charlson Index ≥2, n (%) 24 (85.7%) 26 (86.7%) 1
Indicators of clinical deterioration III, n (%) 21 (75%) 25 (83.3%) 0.434
Conditions to determine frequent use of healthcare services IV, n (%) 19 (67.9%) 24 (80%) 0.291
Adequate treatment adherence (Morisky Adherence Scale), n (%) 28 (100%) 29 (96.7%) 1
Use of healthcare resources over the year prior to inclusion
Regular medicines/day, mean (SD) 10.1 (3.1) 11.1 (3.3) 0.240
All-cause hospitalisations, mean (SD) 3.4 (1.7) 3.4 (1.7) 0.981
Cause-specific hospitalisationsV, mean (SD) 2.6 (1.5) 2.6 (1.5) 0.891
Length of stay (days/admission), mean (SD) 11.3 (6) 10.4 (7) 0.207
Emergency department attendances not resulting in admission, median (IQR) 1 (0 – 5) 1 (0 – 6) 0.920
Appointments with specialists, median (IQR) 3 (0 – 13) 2.5 (0 – 12) 0.129
Home visits, median (IQR) 20.0 (3 – 139) 23.5 (3 – 67) 0.291
Telephone contacts, median (IQR) 3 (0 – 22) 3.5 (0 – 20) 0.619
IG: intervention group; CG: control group. The data are expressed as frequency and percentage (%) for categorical variables, and as mean with the standard
deviation (SD) or median with the interquartile range (IQR) for continuous variables.
I Chi-square or Fisher’s exact tests were used to compare categorical variables and Student’s t-tests or non-parametric Wilcoxon tests to compare continuous variables.
II Based on the assessment of social factors including poverty, loneliness, isolation, social exclusion, and recent widowhood.
III Presence of at least one of the following characteristics: bone and joint disease, ischaemic heart disease, sequelae of cerebrovascular accident, Parkinson’s
disease, diabetes, obesity (body mass index >30), visual or hearing impairment, current mental illness (receiving treatment), or other factors considered relevant
by the patient’s doctor and documented.
IV On acenocoumarol and/or presence of pressure ulcers and/or need for regular dressing changes or injections.
V Admissions to hospital for respiratory and heart-related problems.
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Table 2 Hospital admissions and length of stay during the follow-up period in the intervention and control groups
At 3 months At 6 months At 12 months
IG CG p IG CG p
valueI
IG CG p valueI
(n = 25) (n = 29) valueI (n = 25) (n = 28) (n = 21) (n = 22)
All-cause hospitalisations 0.744 0.887 0.250
mean (SD) 0.5 (0.8) 0.4 (0.6) 1.2 (1.7) 1 (1.3) 2.1 (2.8) 2.1 (1.5)
median (IQR) 0 (0–1) 0 (0–1) 0 (0–2) 1 (0–1) 1 (0–3) 2 (1–3)
All-cause hospitalisations categorised 0.907 0.506 0.033
0 admisssions, n (%) 16 (64%) 19 (65.5%) 13 (52%) 12(42.9%) 9 (42.9%) 3 (13.6%)
≥1 admisssions, n (%) 9 (36%) 10 (34.5%) 12 (48%) 16 (57.1%) 12 (57.1%) 19 (86.4%)
RR (95% CI) 1 (0.5 – 2.2) 0.8 (0.5 – 1.4) 0.7 (0.4 – 0.9)
Cause-specific hospitalisationsII 0.895 0.732 0.328
mean (SD) 0.4 (0.7) 0.3 (0.6) 0.9 (1.3) 0.9 (1.3) 1.8 (2.6) 1.8 (1.6)
median (IQR) 0 (0–1) 0 (0–1) 0 (0–1) 0.5 (0–1) 1 (0–2) 1.5 (1–2)
Cause-specific hospitalisations categorised 0.973 0.465 0.159
0 admisssions, n (%) 18 (72%) 21 (72.4%) 15 (60%) 14 (50%) 9 (42.9%) 5 (22.7%)
≥1 admisssions, n (%) 7 (28%) 8 (27.6%) 10 (40%) 14 (50%) 12 (57.1%) 17 (77.3%)
RR (95% CI) 1 (0.4 – 2.4) 0.8 (0.4 – 1.5) 0.7 (0.5 – 1.1)
Length of stay (days/admission)III
all-cause hospitalisations, mean (SD) 8.7 (2.3) 11.2 (8.9) 0.954 8.2 (3.3) 8.2 (5.3) 0.477 9.0 (4.3) 10.7 (11.2) 0.891
cause-specific hospitalisations, mean (SD) 8.9 (2.4) 11.6 (9.1) 0.936 8.4 (3.2) 8.3 (5.0) 0.497 9.0 (4.5) 11.2 (11.8) 0.927
IG: intervention group; CG: control group; RR: relative risk of the occurrence of at least one admission; CI: Confidence interval.
The data are expressed as frequency (percentage) for categorical variables, and as mean and standard deviation (SD) and median and interquartile range (IQR) for
continuous variables, unless otherwise stated.
I Chi-square or Fisher’s exact tests were used to compare categorical variables and Student’s t-tests or non-parametric Wilcoxon tests to compare continuous
variables at each time point.
IIAdmissions to hospital for respiratory and heart-related problems.
III Mean length of stay per admission (hospitalisation), considering only patients who were admitted at least once (12 in the IG and 19 in the CG).
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sidered for subsequent analysis.
Impact of home telemonitoring on the length of hospital
stay
Considering the patients who completed the 12 month
follow-up, the mean length of hospital stay was shorter
among patients in the IG for both, all-cause admissions
(mean 9, SD 4.3 days vs. 10.7, SD 11.2 days) and cause-
specific admissions (mean 9, SD 4.5 days vs. 11.2, SD
11.8 days), although the differences were not statistically
significant. A total of 121 hospital admissions were regis-
tered among participating patients. Taking into account
the causes that led to the hospitalisations, the most com-
mon where related to problems with the respiratory system
(47.1%), followed by those related to the cardiovascular
system (27.3%) and the two conditions occurring simul-
taneously (10.7%). Overall, 81% of the admissions were
cause-specific. The main cause of cardiovascular-related
admissions (84.8%) was HF (33.3% in combination with
respiratory exacerbation), while most of the respiratory-
related admissions (94.3%) were due to acute respiratory
exacerbations (37.9% and 19.7% in association with respi-
ratory infections and HF, respectively).Effect of home telemonitoring on mortality
At the end of the 12-month follow-up period, 3 indivi-
duals died in the IG (12.5%) and as compared to 8 in the
CG (26.7%), the difference not being statistically signifi-
cant (p = 0.310). Among the patients in the IG, the
deaths were attributable to HF and COPD relapse in one
case, to cholecystitis in another and to multi-organ fail-
ure associated with prosthetic valve endocarditis in the
last case. Among the patients in the CG, 5 of the deaths
were related to problems with the respiratory system, 2
to HF and in 1 case the cause of death was not deter-
mined (the patient died at home).
Effect of home telemonitoring on the use of other
healthcare resources
With regard to home visits, overall there were fewer
visits conducted by either GPs or nurses among patients
in the IG. Focussing on the analysis of the visits per-
formed by nurses, there were a mean of 15.3 and 25.4
home nursing visits per patient in the intervention and
control groups, respectively, though the difference was
not statistically significant. The only variable in which
significant differences were found between the two study
groups at 12 months of follow-up was the number of
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fessionals, this being higher among patients in the IG
(p = 0.001) (see Figure 2). Figure 3 shows the comparison
of the home visits and telephone contacts registered
among patients in the intervention group depending on
the inclusion disease (HF, CLD, or both).
The comparison of the hospital admissions and the
use of other healthcare resources that occurred in the
year prior to the inclusion in the study and the year of
follow-up are shown in Table 3. A significant decrease in
the number of all-cause hospital admissions in both
groups was observed (a mean of 1.3 fewer in the IG and
1.1 fewer in the CG; p = 0.033). We also found a signifi-
cant increase in the number of telephone contacts in the
IG (p < 0.001) in the follow-up period, and a conside-
rable decrease in the number of appointments with the
specialists (p = 0.033) and the number of appointments
at the primary care health centres (p = 0.015); such
changes were statistically different with respect to the
changes in the means that occurred among patients in
the CG.
Registered telemonitoring alerts
A total of 153.5 (SD 75.8) alerts were generated per
patient over the total follow-up period of study for those
patients using the telemonitoring devices. The most com-
mon cause that triggered such alerts was the detection of
clinical values out of the pre-established threshold, specif-














Figure 2 Comparison of resource use at Health Centres in the IG and
patient among those who completed the 12-months of follow-up. * The on
(p = 0.001). IG: intervention group; CG: control group; HC: health centre.and oxygen saturation (21.2%). The mean number of
alerts related to the blood oxygen saturation level and
heart-rate in the five days prior to cause-specific admis-
sions was significantly higher than that registered over the
entire monitoring period (Table 4). The number of alerts
generated by each parameter in the five days prior to the
hospital admissions are also shown in Table 4, the highest
percentages being found for blood oxygen saturation
(74.3%), respiratory-rate (64.9%) and negative responses to
the health status questionnaire on the PDA (54.5%). Pa-
tients with heart disease had more oedema in their legs
(27.3%), followed by nocturia (18.2%), while in the patients
with lung disease, alerts were due to increased cough as
compared to the previous day (30.3%), increased sputum
production and changes in the colour of the sputum
(27.3% in both cases). The main measure taken by the
health professionals regarding the alerts was registering
the alert and taking no further action (82.4% of the cases),
followed by making a telephone call (12.6%) or a home
visit (3.3%). Thus, in most cases alerts were false alarms.
Discussion
This study can contribute to shed some light on the im-
pact of home telemonitoring of chronic elderly patients
on healthcare resource use. Furthermore, this research
provides evidence of the feasibility of the use of informa-
tion and communication technology (ICT) applications
by elderly patients with limited computer literacy. The












CG. The figures presented were calculated considering the mean per
ly statistically significant difference was found for telephone contacts
Figure 3 Comparison of home visits and telephone contacts among patients in the intervention classified by disease. The figures
presented were calculated considering the mean per patient among those patients in the intervention group who completed the 12-months
of follow-up.
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comorbidity on healthcare resource usage.
The primary outcome measure was the number of
hospitalisations at 12 months post-randomisation. In this
respect, it was particularly striking that 42.9% of patients




All-cause hospitalisations −2 (−3 to −1)
Cause-specific hospitalisations −2 (−2 to −1)
Length of stayIII −0.4 (−3.8 to 1.6)
Health centre appointmentsIV −11 (−16 to 0)
Total home care visits −1 (−2 to 12)
Home visits by doctors 0 (−3 to 3)
Home visits by nurses 2 (−2 to 4)
Telephone contacts* 10 (6 to 24)
Emergency department attendances 0 (−1 to 0)
Appointments with specialists* −1 (−2 to 0)
IG: intervention group; CG: control group; IQR: interquartile range.
I A positive/negative difference in the means indicates an increase/decrease in use
compared to the 12 months before the study.
II Wilcoxon signed-rank test assessing whether the differences between the 12-mon
significant, in each group (IG and CG).
III Mean length of stay per admission (hospitalisation), considering only patients wh
IV Appointments with doctors and/or nurses at the health centre concerning the pa
* Statistically significant differences between the two groups in terms of changes fr
appointments, p = 0.035; telephone contacts, p < 0.001; and appointments with spehospital admissions (the mean number of admissions in
the previous year having been 3.4), and such figure was
significantly different from the rate of 13.6% among the
patients in the CG. This trend of a decrease in the number
of hospital admissions is consistent with the results of
other analysis we performed to assess hospitalisations,ar prior to inclusion and the follow-up periodI
p valueII CG p valueII
(n = 22)
median (IQR)
0.042 −1 (−3 to 0) 0.033
0.086 −0.5 (−1 to 0) 0.244
0.733 −1 (−5.5 to 5.3) 0.798
0.015 2 (−6 to 6) 0.801
0.734 5 (−4 to 8) 0.152
1 0 (−2 to 2) 0.745
0.281 1 (−5 to 9) 0.384
<0.001 3 (0 to 6) 0.147
0.210 0 (−1 to 1) 0.981
0.033 0 (0 to 1) 0.607
of the corresponding healthcare resource in the 12-month follow-up period
th prior to inclusion and the 12-month follow-up period were statistically
o were admitted at least once (12 in the IG and 19 in the CG).
rticipating patients, even if the patients themselves were not present.
om the year prior to inclusion to the follow-up year: total health centre
cialists, p = 0.033. No other statistically significant differences were found.










p valueII % of alerts generated in the
5-day period prior to hospitalisation
%
mean (SD) mean (SD)
SBPIII, mmHg 119.8 (14.7) 121.2 (23) 0.634 38.9%
DBPIII , mmHg 69.1 (6.7) 70.5 (11.3) 0.640 36.1%
Blood O2 saturation,% 93.1 (2.2) 91.0 (4.6) 0.003 74.3%
Heart-rate, bpm 77.8 (14.6) 84.2 (17.1) 0.003 27.8%
Respiratory-rate, bpm 26.3 (4.3) 26.0 (4.1) 0.703 69.4%
Body weightIV, kg 74.4 (23.1) 75.5 (23.2) 0.687 31%
Temperature, °C 35.9 (0.4) 35.5 (1) 0.059 27.8% V
Health status questionnaireVI 54.5%
SD: Standard deviation.
I Considering cause-specific admissions to hospital for respiratory and heart-related problems.
II Obtained using the t-test for dependent samples, comparing the overall mean for each parameter and the mean in the 5 days before the admissions.
III SBP and DBP stand for systolic and diastolic blood pressure, respectively.
IV Considering only patients for whom weight data were recorded. Alerts were generated when ≥2 kg were gained over a period of 3 days.
V Only 3 (5.6%) of alerts were for body temperatures over 37°C, the rest being for values below the lower limit.
VI Negative responses to any of the health status questionnaires (on the personal digital assistant) generated alerts.
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significance: comparison of the number of admissions per
patient; ORs for hospitalisations; NNTs and the compari-
son of the values in the year prior to inclusion relative to
those during the 12 months of follow-up.
The observation that telemonitoring can reduce hos-
pital admission is in agreement with the results of other
benchmark studies. In the Whole System Demonstrator
study, patients in the IG had fewer admissions, with an
OR of 0.82 (95% CI 0.70 to 0.97) [8,9]. Similarly, in the
meta-analysis by Polisena and colleagues concerning HF
[5] three RCTs [16-18] yielded an overall RR of 0.77
(95% CI 0.65 to 0.90), and in a meta-analysis on COPD
by the same authors [6] two studies [19,20] demon-
strated a decrease in the number of admissions of 32%
to 46% among patients included in the IG. Further, an-
other meta-analysis on HF [21] found a protective effect
with a RR of 0.93 for all-cause admissions and of 0.71
for specific admissions due to HF, the latter being statis-
tically significant. The 2010 Cochrane review [4] showed
that telemonitoring decreased the number of total hos-
pital admissions and admissions due to HF by 44% and
21%, respectively, thus confirming the findings of earlier
research [21].
The majority of the hospital admission that occurred
during the completion of the study were cause-specific
(81%), that is, for health problems related to one of the
two health conditions considered in the present study
(HF and CLD). In this respect, 84.8% of the admissions
related to cardiovascular problems were due to HF, while
94.3% of respiratory-related admissions were due to re-
spiratory exacerbations. This fact underlines the impor-tance of a good clinical management of the aforemen-
tioned conditions and, especially, the significance of the
early detection of the episodes of worsening or exacerba-
tion, as the conditions with which patients have been diag-
nosed are responsible for most of the admissions. In this
sense, it is essential that when applying telemonitoring in-
terventions, a good disease management is combined with
the deployment of the technology.
Additionally, a trend towards shorter hospital stays
among telemonitored patients was also observed. In this
regard, the mean days of hospital stay for those patients
who completed 12 months of follow-up was of 9 days in
the IG vs. 10.7 days in the CG, despite the differences ob-
served were not statistically significant. Moreover, consid-
ering the total 121 hospital admissions that occurred
during the study, the length of hospital stay due to all
causes was 9.6 days vs. 12.2 days and number of days in
hospital due to specific causes was 9.8 vs. 12.5, in the
intervention and control groups, respectively, although
the differences were not statistically significant. Several
other authors have reported decreases in the length of
hospital stay in patients with HF and COPD [4,6,8,22], but
results are not consistent across all studies [23] and some
RCTs have shown the opposite effect [22,24].
Regarding the impact of home telecare on mortality,
fewer deaths were observed among patients in the IG
than in the CG (3 vs. 8 patients) and the mortality-rate
was lower than would be expected with respect to esti-
mates based on published data and our statistics from
previous years for patients with similar characteristics.
Nevertheless, the sample size of the present study is not
large enough to draw solid conclusions. To date, several
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nitoring was used on HF patients [4,5,8,10,21,23], but
there is no consensus for the aforementioned condition
[23], and even less consistent results have been pub-
lished for patients with COPD [6].
During the course of the study, home telemonitoring of
the trial patients led to changes in how care was delivered
by the participating primary care health centres. In this re-
spect, there were significantly more telephone contacts be-
tween telemonitored patients and their GPs and/or nurses
(with a mean of 22.6 telephone calls per patient in the IG,
vs. 8.5 in the CG) and fewer home visits, mainly due to
significantly fewer home nursing visits (with a mean of
15.3 nursing visits per patient in the IG vs. 25.4 in the
CG). A very slight increase in home visits by GPs was
however observed in the IG, which we believe may be
influenced by a closer delivery of care and increased initial
actions undertaken by doctors, until the participating GPs
became familiar with the telemonitoring process. Thus, as-
suming that the intervention is effective decreasing the
number of hospitalisations, such redistribution of health-
care activities and resources may entail savings, consider-
ing the costs associated with telephone contacts compared
to home visits. On the other hand, these changes could
have a significant impact on the way primary care profes-
sionals work, leaving more time for nurses to spend on
other relevant task that could improve the management of
this type of patients. Nonetheless, the impact of such ope-
rational modifications has not been directly addressed in
this study and requires further investigation. Few studies
have assessed the effect of home telemonitoring on tele-
phone calls and home visits and although some studies
have been consistent with our findings [20], others were
not [4].
We believe that when assessing the impact and overall
implications of home telemonitoring it is essential to con-
sider the global effects of the technology itself in addition
to the usage of healthcare resources. Thus, other complex
factors such as, the organizational changes, standards and
perceptions of health and safety, effect on the patients’
QoL, economical implications, patients’ and healthcare pro-
fessionals’ satisfaction as well as the effect of telemonitoring
on family caregivers should also be taken into account.
Some of these aspects have been assessed by our team and
will be published shortly. A cost-effectiveness analysis of
the TELBIL study has also been undertaken [25].
We would like to highlight three key characteristics that
differentiate this study from others and make it particu-
larly relevant. Firstly, the telemonitoring was managed by
primary care professionals (GPs and nurses) who regularly
see the patients in the health centres or at home. The fact
that primary care professionals are in charge of the
telemonitoring intervention is particularly important,
since these are the healthcare professionals that routinelycarry out the follow-up of in-home patients and, thus,
telemonitoring could have a greater positive impact than
when applied to hospital-based interventions. In this re-
gard, the integration of the new telemonitoring interven-
tion to the routine practice at the health centres could
improve the care provided. To the best of our knowledge,
this is one of the first RCTs in which primary care profes-
sionals are in charge of the telemonitoring procedure. The
implication of primary healthcare professionals has been
further explored in the present study. On the one hand,
the implication of around 70 primary care professionals
has enabled us to undertake a qualitative analysis with
focus groups to further assess the satisfaction and specific
contribution of the participating GPs and nurses [26]. On
the other hand, the factors related to the healthcare pro-
fessionals’ acceptance of the new telemonitoring techno-
logy have been evaluated through and extension of the
Technology Acceptance Model (TAM), showing that the
perception of facilitators in the organisational context is
the most important variable to consider for increasing
healthcare professionals’ intention to use the telemo-
nitoring technology [27].
Secondly, the patients included in the present study had
challenging characteristics: they had a higher mean age
(81 years) than that targeted by most other published
studies [4-6] and were patients with advanced diseases
and high levels of comorbidity (51.7% were under home
oxygen therapy, 46.5% had both of the diseases targeted in
this study, 86.2% scored high comorbidity (>2) on the
Charlson index and 79.3% showed signs of clinical dete-
rioration) and, in line with these features, the patients
included in the trial were heavy users of healthcare re-
sources. In the view of the above mentioned peculiarities,
this trial demonstrates the feasibility of implementing
telemonitoring interventions as an alternative mode of
health care provision for medically unstable patients with
high degree of physical and functional deterioration. Fur-
thermore, there were only 5 individuals not wishing to
continue using the telemonitoring system and even these
had all successfully managed to handle the devices. The
observed low dropout-rate contrasts with other research
into the feasibility and perceptions of this technology,
which suggests that the older the patient and/or caregiver
the more obstacles to the adoption of telemonitoring [28].
Thirdly, we have focussed on two common chronic dis-
orders (HF and CLD), which have been managed using
the same telemonitoring system and in a very similar way,
while practically all previous RCTs on telemonitoring
technology have targeted a single chronic condition [29].
This point is important, since the levels of comorbidity
among this kind of patients make it difficult to consider a
single condition in isolation from other existing health
problems. Hence, the telemonitoring management ap-
proach should be adapted to reflect the clinical and
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specific disease.
Study limitations
The results of our study should be interpreted in light of
some limitations. First, the number of patients included
in the study was limited by the available telemonitoring
devices. Twenty eight patients received telemonitoring
and 21 patients in the IG and 22 patients in the CG
completed the follow-up. We have, therefore, observed a
deviation in the estimated power mainly due to an in-
crease in the expected losses and a lower reduction in
the number of hospital admissions than previously en-
visaged. We have recalculated the statistical power, ta-
king into account the results obtained, with a confidence
level of 95% in a bilateral contrast and 21 patients in the
IG and 22 in the CG. Thus, the present study has a
statistical power of 58% to detect significant differences
between the percentages of patients with ≥1 hospital ad-
missions in the IG (57.1%) and in the CG (86.4%).
Another limitation of this study is that due to the inter-
active nature of the intervention, it was not possible to
blind the health care professionals providing the interven-
tion or the participants involved in the study. However,
despite this limitation, most of the data presented in this
manuscript are objective and have been obtained from
medical registers. The veracity of the data obtained has
been double-checked and the statisticians in charge of the
data analysis have been blinded to group assignment.
Conclusions
Our study shows that primary care-based telemonitoring
increases the percentage of in-home patients with no
hospital admissions after 12 months of follow-up. We
also observed trends towards fewer all-cause and cause-
specific admissions, as well as shorter hospital stays.
We have also observed that telemonitoring leads to a
significant increase in the number of telephone contacts
between healthcare professionals and patients, but this is
balanced by a decrease in the use of other healthcare
services provided by primary care health centres, par-
ticularly, home nursing visits.
The present study demonstrates the feasibility of this
mode of healthcare provision in elderly patients with high
levels of comorbidity and limited computed literacy.
Prior to the implementation of telemonitoring interven-
tions, it is essential to reach beyond the mere techno-
logical aspects, paying attention to the proper clinical
management of the patient’s condition and the impact of
the telemonitoring on healthcare professionals, patients
and their families.
Further studies are required in primary care settings
involving patients with common chronic illnesses and
comorbidities. Future research should also analyse thedifferent elements of the overall intervention, identifying
those with the greatest effects.
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